TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUSNGlobeNewswireApril 22, 2024NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating:
Alpine Immune Sciences, Inc. (Nasdaq: ALPN), relating to its proposed sale to Vertex Pharmaceuticals Inc.. Under the terms of the agreement, ALPN shareholders are expected to receive $65.00 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/alpine-immune-sciences-inc/. It is free and there is no cost or obligation to you.Landos Biopharma, Inc. (NASDAQ: LABP), relating to its proposed sale to AbbVie, Inc. Under the terms of the agreement, LABP shareholders are expected to receive $20.42 in cash plus one non-tradable CVR worth up to $11.14 per share they own. Click here for more information: https://monteverdelaw.com/case/landos-biopharma-inc/. It is free and there is no cost or obligation to you.Shockwave Medical, Inc. (NASDAQ: SWAV), relating to its proposed sale to Johnson & Johnson. Under the terms of the agreement, SWAV shareholders are expected to receive $335.00 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/shockwave-medical-inc/. It is free and there is no cost or obligation to you.Fusion Pharmaceuticals Inc. (NASDAQ: FUSN), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, FUSN shareholders are expected to receive $21.00 in cash plus one non-tradable CVR worth up to $3.00 per share they own. Click here for more information: https://monteverdelaw.com/case/fusion-pharmaceuticals-inc/. It is free and there is no cost or obligation to you.Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court?When was the last time you recovered money for shareholders?What cases did you recover money in and how much?About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:Juan Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4740New York, NY 10118United States of Americajmonteverde@monteverdelaw.comTel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
COMTEX_451246577/2010/2024-04-22T17:33:46
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating:
Alpine Immune Sciences, Inc. (Nasdaq: ALPN), relating to its proposed sale to Vertex Pharmaceuticals Inc.. Under the terms of the agreement, ALPN shareholders are expected to receive $65.00 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/alpine-immune-sciences-inc/. It is free and there is no cost or obligation to you.Landos Biopharma, Inc. (NASDAQ: LABP), relating to its proposed sale to AbbVie, Inc. Under the terms of the agreement, LABP shareholders are expected to receive $20.42 in cash plus one non-tradable CVR worth up to $11.14 per share they own. Click here for more information: https://monteverdelaw.com/case/landos-biopharma-inc/. It is free and there is no cost or obligation to you.Shockwave Medical, Inc. (NASDAQ: SWAV), relating to its proposed sale to Johnson & Johnson. Under the terms of the agreement, SWAV shareholders are expected to receive $335.00 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/shockwave-medical-inc/. It is free and there is no cost or obligation to you.Fusion Pharmaceuticals Inc. (NASDAQ: FUSN), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, FUSN shareholders are expected to receive $21.00 in cash plus one non-tradable CVR worth up to $3.00 per share they own. Click here for more information: https://monteverdelaw.com/case/fusion-pharmaceuticals-inc/. It is free and there is no cost or obligation to you.Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court?When was the last time you recovered money for shareholders?What cases did you recover money in and how much?About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:Juan Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4740New York, NY 10118United States of Americajmonteverde@monteverdelaw.comTel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
COMTEX_451246577/2010/2024-04-22T17:33:46
0.00% $0.00
